- Home
- GIGM vs XAIR Comparison
GIGM vs XAIR Comparison
Compare GIGM & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- XAIR
- Stock Information
- Founded
- GIGM 1998
- XAIR 2011
- Country
- GIGM Taiwan
- XAIR United States
- Employees
- GIGM N/A
- XAIR N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- XAIR Medical/Dental Instruments
- Sector
- GIGM Technology
- XAIR Health Care
- Exchange
- GIGM Nasdaq
- XAIR Nasdaq
- Market Cap
- GIGM 17.8M
- XAIR 17.0M
- IPO Year
- GIGM 2000
- XAIR N/A
- Fundamental
- Price
- GIGM $1.58
- XAIR $1.47
- Analyst Decision
- GIGM
- XAIR Strong Buy
- Analyst Count
- GIGM 0
- XAIR 1
- Target Price
- GIGM N/A
- XAIR $11.00
- AVG Volume (30 Days)
- GIGM 6.8K
- XAIR 1.2M
- Earning Date
- GIGM 10-30-2025
- XAIR 11-10-2025
- Dividend Yield
- GIGM N/A
- XAIR N/A
- EPS Growth
- GIGM N/A
- XAIR N/A
- EPS
- GIGM N/A
- XAIR N/A
- Revenue
- GIGM $3,397,000.00
- XAIR $5,802,000.00
- Revenue This Year
- GIGM N/A
- XAIR $261.11
- Revenue Next Year
- GIGM N/A
- XAIR $151.82
- P/E Ratio
- GIGM N/A
- XAIR N/A
- Revenue Growth
- GIGM 10.11
- XAIR 147.74
- 52 Week Low
- GIGM $1.38
- XAIR $1.36
- 52 Week High
- GIGM $1.89
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- GIGM 39.01
- XAIR 25.97
- Support Level
- GIGM $1.58
- XAIR $1.36
- Resistance Level
- GIGM $1.66
- XAIR $1.84
- Average True Range (ATR)
- GIGM 0.04
- XAIR 0.15
- MACD
- GIGM -0.01
- XAIR -0.06
- Stochastic Oscillator
- GIGM 21.41
- XAIR 12.50
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.